Pancreatic Cancer Detection Using Advanced Tissue Analysis
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study tests a new way to analyze tiny samples of pancreatic tissue taken during a biopsy to better detect cancer. The method uses special technology to examine the physical properties of cells, which may help doctors diagnose pancreatic cancer more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You can understand the study and sign a consent form
- Your doctor has recommended a needle biopsy of a suspicious pancreatic growth
- The pancreatic lesion (abnormal area) can be safely reached with a biopsy needle
- You do not have any serious medical conditions that would make the biopsy unsafe for you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tissue samples from people having surgery for a suspected pancreatic growth to find markers that might help diagnose pancreatic cancer earlier. By studying the removed tissue, researchers hope to learn more about the earliest changes that lead to cancer.
This study is testing a new blood test to find pancreatic cancer early. It looks for tiny bits of cancer DNA floating in your blood, which could help catch the disease before symptoms start.
This study looks for proteins in the blood that could help doctors tell the difference between pancreatic cancer and non-cancerous pancreatic conditions, such as chronic pancreatitis or benign cysts. By participating, you could help improve early and accurate diagnosis, which may lead to better outcomes for future patients.
This trial studies metastatic pancreatic cancer by taking a small tissue sample and analyzing its genes. It may help doctors better understand which cancer subtypes patients have, which can guide future treatment choices.
This study looks at “biomarkers” (test signals in tissue or blood) in people with pancreatic cancer. It may help researchers understand the disease better and find ways to predict or track it.
This study follows how pancreatic cancer changes over time while you’re receiving treatment before surgery. It may help doctors understand how the cancer evolves and guide better future treatment choices.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.